The Emerade Auto Injector is an intuitive 2-step, intramuscular Adrenaline Auto Injector (AAI) for the emergency treatment of anaphylaxis. The design of this next-generation AAI reflects vital feedback from allergy specialists and patients, which have been incorporated to enhance usability and dose efficacy. The results from a study conducted in a simulated emergency situation further proved the intuitiveness of the Emerade device over its competitors.
In cooperation with SHL, the Emerade Auto Injector is a product of Medeca Pharma, a Swedish pharmaceutical company specializing in allergy since 1991. The device is currently licensed by Valeant Pharmaceutical International and is available in the UK, Germany and Sweden.